Safety Assessment Services

Your Success is Our Biggest Achievement
At WuXi AppTec, we care passionately about the success of your program. We understand the importance of meeting drug development milestones, giving you robust data and keeping your drug on the path to success.

Whether you’re working on an innovative small molecule or an advanced biologic drug candidate, you can rely on our Safety Assessment team to develop a program that meets your specific needs.

Compliance You Can Count On
Our programs are fully compliant with the requirements of the U.S. Food and Drug Administration (FDA), Organization for Economic Co-operation and Development (OECD), and the National Medical Products Administration (NMPA) Good Laboratory Practice (GLP). Studies are conducted in state-of-the-art facilities that are fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) and overseen by highly experienced Testing Facility Management (TFM) experts.

Full-Scale Testing Platform for On-Time Delivery, Every Time
We offer our global clients a full-scale testing platform for all stages of drug development. Whether you need a four-week rodent study to support an IND filing or a two-year carcinogenicity study for an NDA, we have completed thousands of studies in our ultra-modern 645,800 square foot facility comprising 300 animal rooms.

A History of Service and Quality
Our Safety Assessment services are fully integrated within our comprehensive testing platform, which, when applied to projects handled end to end, allows us to provide the multidisciplinary expertise and experience that saves significant time and cost while yielding invaluable data and insights.

Approximately 25% of our safety assessment staff at the WuXi AppTec facility in Suzhou, China have graduate degrees, and the senior management team has international experience – holding certifications from Diplomate of the American Board of Toxicology (DABT) and the European Registered Toxicologist (ERT), among others.